Daniel Galvão is Professor of Exercise Science and Director of the Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, and a Cancer Council Western Australia Research Fellow. He received his B.Sc. (1998, Brazil) in Physical Education, M.Sc. (2003) in Clinical Exercise Science from the University of Queensland and his Ph.D. (2006) in Exercise Science from Edith Cowan University. Professor Galvão’s research program focuses on applications of exercise as medicine for the prevention and management of cancer treatment side effects and survival and has received funding from NHMRC, Cancer Australia and the Prostate Cancer Foundation of Australia. His research has been published in the Journal of Clinical Oncology, European Urology and Nature Reviews Urology and he has co-authored the Exercise and Sports Science Australia position stand in exercise and cancer (2009) and the American College of Sports Medicine’s exercise guidelines for cancer survivors (2010).
- Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005 Feb 1;23(4):899-909. Impact Factor: 26.303.
- Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010 Jan 10;28(2):340-7. Impact Factor: 26.303.
- Newton RU, Taaffe DR, Chambers SK, Spry N, Galvão DA. Effective Exercise Interventions for Patients and Survivors of Cancer Should be Supervised, Targeted, and Prescribed With Referrals From Oncologists and General Physicians. J Clin Oncol. 2018 Mar 20;36(9):927-928. doi: 10.1200/JCO.2017.76.7400. Epub 2018 Jan 26. PubMed PMID: 29373097. Impact Factor: 26.303.
- Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU. A multicentre year-long randomized controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. European Urology. 2014;65(5):856-64. Impact Factor: 17.581.
- Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall B, Cormie P, Bolam KA, Galvão DA. Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. European Urology, 2017. doi: 10.1016/j.eururo.2017.02.019. Impact Factor: 17.581.
- Newton RU and Galvão DA. Accumulating Evidence for Physical Activity and Prostate Cancer Survival: Time for a Definitive Trial of Exercise Medicine? European Urology, 2016 Apr 23. pii: S0302-2838(16)30077-X. doi: 10.1016/j.eururo.2016.04.018. Impact Factor: 17.581.
- Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvão DA et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017 Jan;52:91-104. doi: 10.1016/j.ctrv.2016.11.010. Impact Factor: 8.122.
- Buffart LM, Galvão DA, Brug J, Chinapaw MJ, Newton RU. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014 Mar;40(2):327-40. Impact Factor: 8.122.
- Galvão DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger G, Frydenberg M, Hill M, Chambers SK, Stricker P, Shannon T, Hayne D, Zopf E, Newton RU. Enhancing Active Surveillance for Men with Prostate Cancer: The Potential Role of Exercise Medicine. Nature Reviews Urology 2016 doi:10.1038/nrurol.2016.46. Impact Factor: 8.089.
- Galvão DA, Newton RU, Taaffe DR, Spry N. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT? Nature Clinical Practice Urology 2008 Jun;5(6):306-7. doi: 10.1038/ncpuro1104. PubMed PMID: 18431358. Impact Factor: 8.089.
Continuing external funding over the past 15 years (selected from 52 grant ~$17,141,199 in total funded).
- 2018-2022 - National Health and Medical Research Council. Project. $596,083.
- 2017-2021 - National Health and Medical Research Council. Centre for Research Excellence (CRE) Prostate Cancer Survivorship. $2,498,842.
- 2016-2021 - Movember GAP4. Trial coordination. $342,985.
- 2016-2018 - Movember GAP4. Project. $290,544.
- 2014-2017 - National Health and Medical Research Council. Project. $561,845.
- 2014-2017 - Cancer Council Western Australia Research Fellowship. $320,000.
- 2012-2014 - Cancer Australia. Project. $446,276.
- 2012-2013 - Prostate Cancer Foundation of Australia. Project. $296,820.
- 2011-2014 - Australian Collaborative Research Networks Program. $988,188.
- 2011-2013 - Cancer Australia/Beyond Blue. Project. $598,194
- 2009-2012 - Prostate Cancer Foundation of Australia. Project. $476.024.
- 2009-2011 - National Health and Medical Research Council. Project. $500.000.
- 2007-2008 - Prostate Cancer Foundation of Australia. Project. $244.328.
Contributions to NHMRC and Peer Review
Galvão has been a Grant Review Panel (GRP) Member on NHMRC Project Grants (2011 GRP Musculoskeletal), (2012 GRP Clinical Medicine and Musculoskeletal), NHMRC Australian Prostate Cancer Research Centres Expert Review Committee Member (2015-2016), and Cancer Council of Western Australia Research Committee Member (2009-2018), and has reviewed project grant applications for various national (NHMRC, ARC and PCFA) and international research agencies including USA, Canada, Germany, Denmark, Italy, England and the Netherlands. He has been the Chair (2013-2016) of the Research Grants Pre-Doctoral Sub-committee of the Cancer Council of WA, Chair of the Prostate Cancer Foundation of Australia John Mills Young Investigator Research Award (2017) and member of the Editorial Board of three international Journals and regular reviewer for 36 journals (e.g. Journal of Clinical Oncology >13X).
- 2018-current: Director, Exercise Medicine Research Institute, Edith Cowan University, WA, Australia.
- 2015-current: Co-Director, Exercise Medicine Research Institute, Edith Cowan University, WA, Australia.
- 2015 Jul-Dec: Visiting Research Fellow, German Sport University Cologne [Deutsche Sporthochschule Köln], Cologne, Germany.
- 2014-2015: Co-Director, Edith Cowan University Health and Wellness Institute, Edith Cowan University, WA, Australia
- 2014-2017: Cancer Council Western Australia Research Fellow
- 2012-current: Professor of Exercise and Sports Science, Edith Cowan University Health and Wellness Institute, WA, Australia.
- 2010-2013: Director, Edith Cowan University Health and Wellness Institute, Edith Cowan University, WA, Australia.
- 2010-2012: Associate Professor of Exercise and Sports Science, School of Exercise and Health Sciences, Edith Cowan University, WA, Australia.
- 2009-2010: Acting Director, Vario Health Institute, Edith Cowan University, WA, Australia.
- 2009-2010: Senior Research Fellow - School of Exercise, Biomedical and Health Sciences, Edith Cowan University, WA, Australia.
- 2007-2008: Post-Doctoral Research Fellow, School of Exercise, Biomedical and Health Sciences and Vario Health Institute, Edith Cowan University, WA, Australia.
- 2006-2007: Post-Doctoral Research Fellow, Centre of Excellence for Alzheimer’s Disease Research and Care, Edith Cowan University, WA, Australia.
Awards and Recognitions
- 2015 - Prostate Cancer World Conference Award for best paper in Allied Health category, for Hart et al. Musculoskeletal comparisons of prostate cancer patients with localised versus metastatic disease progression.
- 2014 - Edith Cowan University Vice-Chancellor's Award for Excellence in Research.
- 2014 - 21st Hong Kong International Cancer Congress, Li Ka Shin Faculty of Medicine, Hong Kong University best poster in psychosocial oncology for M Tse et al. Study protocol for exercise as medicine for men with prostate cancer in Hong Kong - a randomized controlled trial.
- 2014 - Edith Cowan University one of the most highly cited researchers in the past 5 years.
- 2013 - Prostate Cancer World Conference Award for best paper in Allied Health category, for Newton et al. Can exercise prevent treatment toxicity in prostate cancer patients initiating androgen suppression therapy: a randomised controlled trial.
- 2012 - Western Australia Tall Poppy Scientist of the Year 2012. Australian Institute of Policy and Science
- 2011 - Finalist Western Australia Science Awards, Early Career Scientist of the Year The Government of Western Australia.
- 2011 - Edith Cowan University’s top Research Activity Index performer for the year of 2010.
- 2011 - Second prize at Australasian Prostate Cancer Conference Poster Award for Urology Category, for: Peddle-McIntyre, et al. Presented at 12th Australasian Prostate Cancer Conference, Melbourne, Australia.
- 2010 - Edith Cowan University’s Top Research Activity Index performer for the year of 2009.
- 2009 - Government of Western Australia Department of Health. New Independent Researcher Infrastructure Support (NIRIS) Award. 2009. (Award $10,000).
- 2009 - ECU Vice-Chancellor’s Award for Research by Early Academics.
- 2009 - Australian Sports Medicine Federation Fellows Award Highly Commended Paper in the Category of Performance Enhancement and Basic Science. Be Active, Brisbane, 14-17 October 2009.
- 2007 - Exercise Sports Science Australia (ESSA) Medal for Most Outstanding PhD Thesis in Australia.
- 2007 - The Cancer Council of Western Australia first launched Early Career Investigator Grant.
- 2004 - Young Investigator Award at the Pre-Olympic Conference - International Council of Sport Science and Physical Education Development Award, Thessaloniki, Greece.
- 2003 - Journal of Science and Medicine in Sport Award for Best Poster Injury Prevention and Health Promotion Australian Association of Science and Medicine in Sport at the Australian Conference of Science and Medicine in Sport, Canberra, Australia.
- 2003 - Short listed for the Ken Maguire Award for best young investigator (Clinical Exercise) Australian Association of Science and Medicine in Sport at the Australian Conference of Science and Medicine in Sport, Canberra, Australia.
Research Areas and Interests
- Applications of exercise as medicine for the prevention and management of cancer treatment side-effects and survival.
- European Association of Urology (EAU)
- American College of Sports Medicine (ACSM)
- American Society of Clinical Oncology (ASCO)
- Exercise and Sports Science Australia (ESSA)